logo
Plus   Neg
Share
Email

SNC-Lavalin Receives One-year Extensions From Bruce Power On Two Contracts - Quick Facts

SNC Lavalin Group Inc. (SNCAF,SNC.TO) said Wednesday that Candu Energy Inc., a member of the SNC-Lavalin Group, has been awarded one-year extensions from Bruce Power on two existing contracts.

The company will continue to provide fuel channel inspection, and tooling maintenance and refurbishment in support of reactor inspection and maintenance.

As part of the extensions, SNC-Lavalin will support Bruce Power in executing three fuel channel inspection outages as part of the station's regular outage schedule in 2021. This contract is within SNCL Engineering Services.

"SNC-Lavalin looks forward to the renewed opportunity with Bruce Power and supporting its continued safe operation of CANDU units by performing inspections to meet the regulatory codes and standards," said Sandy Taylor, President of Nuclear, SNC-Lavalin.

SNC-Lavalin said it leads the fuel channel inspection programs for these heavy water reactors around the world performing multiple outages each year.

The Bruce Power fuel channel inspections were performed using the Bruce Reactor Inspection and Maintenance System - Advanced Non-Destructive Examination (BRIMS-ANDE System) for over five years.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported that its fourth-quarter net earnings attributable to shareholders rose 23 percent to $35.84 billion from last year's $29.16 billion, with earnings per share improving to $23,015 per Class A share from $17,909 per Class A share in the prior year. Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow. Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced Friday that the European Medicines Agency or EMA has validated for review the Marketing Authorization Application for somatrogon. Pfizer expects a decision from the European Commission in 2022. The company said somatrogon is a long-acting recombinant...
Follow RTT